Cohort Dashboard

GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.

Total Global Data

0
Unique Locations
0
Cohorts
0
Samples Expected
0
Samples Completed

Last Updated: January 14, 2023 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova

Showing 10 of 227 cohort studies.

Central Asian and Transcaucasian PD (CAT-PD) - South Kazakhstan Medical Academy

South Kazakhstan Medical Academy | Shymkent, Kazakhstan
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

Pending
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

Pending
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Tbilisi State Medical University

Tbilisi State Medical University | Tbilisi, Georgia
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

Pending
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

Pending
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 0 Expected

Christchurch Longitudinal Parkinson's Study

Southern Health and Disability Ethics Committee | Christchurch, New Zealand
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 350 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 80 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 430 Expected

Clinical and genetic study of Unusual/Familial Movement Disorders

University of Cincinnati | Cincinnati, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

63 Completed out of 500 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 180 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

63 Completed out of 680 Expected
Ancestry Breakdown for Samples Completed
Show

Clinical and genetic study of Unusual/Familial Movement Disorders - M

University of Cincinnati | Cincinnati, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

6 Completed out of 10 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

6 Completed out of 10 Expected
Ancestry Breakdown for Samples Completed
Show

Clinicogenetic Study of PD in Tunisia

National Institute of Neurology Mongi-Ben Hamida | Tunis, Tunisia
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

43 Completed out of 150 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 150 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

43 Completed out of 300 Expected
Ancestry Breakdown for Samples Completed
Show

CORIELL

CORIELL | Camden, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

4,327 Completed out of 4,478 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

4,389 Completed out of 4,111 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

8,716 Completed out of 8,589 Expected
Ancestry Breakdown for Samples Completed
Show

CSF Biomarkers

University of Perugia | Perugia, Italy
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

0 Completed out of 60 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

0 Completed out of 0 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 60 Expected

DATATOP

Michael J. Fox Foundation | Rochester, United States
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

Pending
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

Pending
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

0 Completed out of 0 Expected

DeNoPa

University of Göttingen | Goettingen, Germany
Access Data on AMP® PD
Number of Samples Completed and Expected
PD Samples
PD Samples

PD samples include clinically diagnosed cases that meet classifying criteria.

131 Completed out of 140 Expected
Non-PD Samples
Non-PD Samples

Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.

136 Completed out of 100 Expected
Total Samples
Total Samples

Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).

267 Completed out of 240 Expected
Ancestry Breakdown for Samples Completed
Show

Submit a Cohort

If you would like to collaborate with GP2, reach out to submit a cohort or get more information on how to become a member.

Request AMP® PD Data Set

As GP2 completes cohort genotyping, all data is shared through the secured AMP® PD platform. Register to request access to this data.

Discover GP2 Members from Around the Globe

Explore the organizational members that make our research possible through their collaboration and contribution of samples and data.